NIH May Lose Primary Care Research Aid

WASHINGTON—NIH may lose a program to train researchers in primary medical care because of congressional concern that the money is going to researchers in other fields. The General Accounting Office has concluded that all 16 of the National Research Service Awards that NIH earmarked for work in primary health care in 1986, totaling $2.1 million, are instead supporting “biomedical research on specific diseases and in specialty areas of medicine rather than primary care.” Awar

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WASHINGTON—NIH may lose a program to train researchers in primary medical care because of congressional concern that the money is going to researchers in other fields.

The General Accounting Office has concluded that all 16 of the National Research Service Awards that NIH earmarked for work in primary health care in 1986, totaling $2.1 million, are instead supporting “biomedical research on specific diseases and in specialty areas of medicine rather than primary care.”

Awards to scientists working in such areas as cellular immunology and cytogenetics comply with the amendment, said Doris Merritt, NIH research training and resources officer, because those fields are “unequivocally training grounds for primary care.”

Murray Grant, GAO’s chief medical officer, called this approach “unreasonable.... It makes no distinction between biomedical research and research in primary medical care, a distinction the Congress clearly intended.”

Congress may be asked next year to shift the program to the Health ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies